Biotech

All Articles

Sanofi's $80M bet on Pivot dystrophy drug ends in period 3 go belly up

.Merely four months after Sanofi bet $80 million in upfront cash money on Key Rehabs' losmapimod, th...

Oncternal equity drains 60% among cutbacks, trial terminations

.Cancer business Oncternal Rehabs is actually folding all its scientific tests and laying off person...

Roche is actually holding out hopes that its own injectable obesity prospect can ultimately demonstrate 25% weight-loss in late-stage trial

.Roche is actually storing out hopes that its own injectable excessive weight prospect could inevita...

Novo Nordisk barrages 'impressive' weight loss result for dual-acting oral medicine in very early test

.Novo Nordisk has actually raised the lid on a stage 1 test of its dental amylin and also GLP-1 rece...

AbbVie takes legal action against BeiGene over blood cancer medicine classified information

.Only a handful of quick weeks after succeeding an FDA Fast Track tag for its investigational BTK de...

Lilly supplies one-two hit with second tranche of favorable records on weekly blood insulin candidate

.Quickly after a good records decline for Eli Lilly's efsitora alfa, the Indianapolis-based business...

BridgeBio reduces gene therapy spending plan as clinical data dissatisfy

.BridgeBio Pharma is lowering its own gene treatment budget and also pulling back from the method af...

GSK surrenders HSV vaccine really hopes after phase 2 fall short, resigning ethnicity to Moderna, BioNTech

.GSK's attempt to develop the initial vaccine for genital herpes simplex infection (HSV) has actuall...

GSK's long-acting bronchial asthma medication halved strikes in phase 3

.GSK's long-acting bronchial asthma treatment has been shown to cut in half the variety of attacks i...

AstraZeneca, Daiichi unload Dato-DXd's total survival stop working

.AstraZeneca and also Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has failed to bo...